| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |